0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Vincristine Neurotoxicity

Thomas R. Chauncey, MD, PhD; John L. Showel, MD; Jacob H. Fox, MD
JAMA. 1985;254(4):507. doi:10.1001/jama.1985.03360040057019.
Text Size: A A A
Published online

To the Editor.—  We had occasion to see a patient who was severely disabled with bilateral foot drop and upper extremity weakness after having received a single dose of vincristine, 2 mg, and other nonneurotoxic medication three weeks earlier. Physical examination was suggestive of a previously inapparent Charcot-Marie-Tooth syndrome.

Report of a Case.—  The patient was a 60-year-old white man diagnosed as having multiple myeloma in June 1983, who had received 15 cycles of melphalan and prednisone through December 1984, followed by local radiation therapy to the left chest wall and cervical spine. In February 1985, the patient received a single 2-mg dose of vincristine (ready-to-use solution) with 25 mg of doxorubicin and 80 mg of prednisone per day for four days. Approximately six days later, the patient reported increasing fatigue with ambulation, an unsteady gait, and decreased dexterity of the hands with paresthesia and hypesthesia of the distal upper

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();